Johnson & Johnson to Separate Orthopedics Unit
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry.
In corporate restructuring news, Johnson & Johnson has announced plans to separate its orthopedics business into an independent company.
Today's briefing also explores the global implications of the Most Favored Nation drug pricing proposal and strategies helping small biotechs reach market faster.
No specific quote available.
Author's summary: Johnson & Johnson separates orthopedics unit.
More News
- Albany Police: Suspect caught on Western Avenue killed sister
- Medicare payments to doctors paused as government shutdown drags on
- Education advocates are worried about the furlough of federal staff supporting special education
- Brad Marchand pulls famous quote to get back at Paul Bissonnette
- ONLY ON 13: Relatives of family killed by drunk driver call for action
- YouTube Down for More Than a Hundred Thousand Users, Downdetector Shows
- Upgraded Apple Vision Pro Gets M5 Muscle, Battery Pass Through, and 120Hz | Man of Many
- Abu Dhabi Partners with Archireef to Use 3D Printing for Coral Reef Restoration - 3Dnatives
- What does Ghana need most? More lawyers or more problem solvers? - Ghana Business News
- Vote in Favor of Recreation: An Essential Service | The Citizen